2013年7月25日木曜日

Nagoya Heart Study

  ・2013年12月13日: 「Nagoya Heart Studyに係る問題についての調査中間報告」を発表した。 名大病院で登録され解析対象となった141人のカルテ、参加医師らが入力したウェブ入力データ、解析用データとエンドポイント委員会の評価の照合した結果、恣意的なデータ操作は無いとの判断を示した。




 2012 Mar;59(3):580-6. doi: 10.1161/HYPERTENSIONAHA.111.184226. Epub 2012 Jan 9.

Comparison between valsartan and amlodipine regarding cardiovascular morbidity and mortality in hypertensive patients with glucose intolerance: NAGOYA HEART Study.

Muramatsu T, Matsushita K, Yamashita K, Kondo T, Maeda K, Shintani S, Ichimiya S, Ohno M, Sone T, Ikeda N, Watarai M,Murohara T; NAGOYA HEART Study Investigators.

Collaborators (213)
Murohara T, Murohara T, Kondo T, Shintani S, Maeda K, Matsushita K, Muramatsu T, Yamashita K,Murohara T, Kondo T, Shintani S, Maeda K, Matsushita K, Muramatsu T, Yamashita K, Akahoshi M,Hirayama H, Ichimiya S, Iida M, Iwama Y, Kaneko S, Kondo T, Marui N, Obayashi T, Ohno M, Ohno O, Osaka T, Sone T, Takada Y, Takanaka C, Watarai M, Matsubara T, Komori K, Doyu M, Toyoshima H, Oiso Y, Hirai M, Shirahashi N (白橋伸雄), Murohara T, Kondo T, Shintani S, Maeda K, Matsushita K, Muramatsu T, Yamashita K,Sasaki K, Watanabe E, Inoue Y, Ajioka M, Amano T, Aoyama T, Aoyama Y, Asano H, Asano Y, Fuchino T,Fujimura T, Fukui R, Futamura Y, Hamaguchi Y, Hanaki Y, Harada K, Harada M, Harata S, Harayama H,Haruta K, Hattori K, Hayashi K, Hayashi Y, Hibino M, Hirashiki A, Ichihara Y, Iino S, Imai H, Inagaki H, Inden Y, Inoue N, Iseki A, Ishii H, Ishikawa K, Ishikawa S, Ishikawa S, Ishiki R, Isobe S, Ito A, Iwata H, Izawa H,Kada K, Kajiguchi M, Kamiya H, Kamiya H, Kanashiro M, Kanayama H, Kataoka Y, Kato M, Kato K, Kato R,Kawaguchi K, Kawai H, Kawakami K, Kawamiya T, Kikuchi S, Kimura A, Kondo K, Kondo T, Koyasu M,Kurebayashi N, Kureishi-Bando Y, Kushiyama Y, Kyo S, Makino M, Matsui H, Matsui Y, Matsunami T, Matsuo K, Matsuyama S, Mitani S, Mitsuhashi H, Miyake H, Mokuno S, Morikawa S, Morimoto R, Morimoto Y, Morita Y, Murakami H, Murata Y, Muto M, Nagao K, Nagata K, Nakagawa H, Nakamura E, Nakashima Y, Nanasato M, Nishimoto Y, Nishimura H, Nishinaka Y, Nishiura T, Nishizawa T, Niwa M, Noda S, Numaguchi Y, Ogawa Y, Ogawa S, Ogura Y, Oguri M, Ohashi T, Ohno J, Okashiro T, Okumura K, Oshima K, Osugi N, Oya M,Saburi Y, Saito M, Sakai K, Sakai S, Sano H, Sato B, Sawada K, Sawasaki K, Shibata T, Shiga Y, Shigeta T,Shimano M, Shimizu A, Shimizu K, Shinoda M, Sobue T, Sugino M, Sugino S, Sugiura H, Suzuki H, Suzuki N,Suzuki T, Tajika T, Takagi K, Takagi K, Takahashi R, Takanari H, Takemoto K, Takemoto Y, Takeshita K,Takeuchi S, Takeuchi T, Tanaka A, Tanaka T, Tanaka T, Tatematsu Y, Terasawa A, Tokuda M, Torigoe M,Torii T, Toriyama T, Tsuboi H, Tsuboi N, Tsukamoto H, Uchida I, Uchikawa T, Uemura Y, Uetani T, Umeda H, Watanabe H, Yamada M, Yamada M, Yamada T, Yamamoto T, Yamauchi M, Yokoi K, Yokoi K, Yokoi K,Yokoyama E, Yoshida T, Yoshida Y, Yoshikane M.

Source

Department of Cardiology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya, 466-8550, Japan.

Sources of Funding

The NAGOYA HEART Study was funded by Nagoya University Graduate School of Medicine. The Department of Cardiology, Nagoya University Graduate School of Medicine, reported receiving research promotion grants (Shougaku Kifukin) from Actelion, Astellas, Bayer, Boehringer Ingelheim, Chugai, Daiichi Sankyo, Dainippon Sumitomo, Eisai, Fuji Film RI, Kaken, Kowa, Kureha, Medtronic, Mitsubishi Tanabe, Mochida, MSD, Novartis, Pfizer, Sanofi-Aventis, Schering-Plough, and Takeda. However, the research topics of these donation grants are not restricted.

Disclosures

To.M. received lecturer's fees from Daiichi Sankyo, Novartis Pharma, Pfizer, and Takeda.

Acknowledgments

We thank Dr Hiroshi Yatsuya (the Department of Public Health, Nagoya University Graduate School of Medicine) for useful comments. We dedicate special recognition to Dr Takao Nishizawa, who passed away on August 2, 2009, after making a significant contribution to the study.
The NAGOYA HEART Study investigators include the following researchers: Principal Investigator: Toyoaki Murohara; Executive Committee: Toyoaki Murohara (chair), Takahisa Kondo, Satoshi Shintani, Kengo Maeda, Kunihiro Matsushita, Takashi Muramatsu, and Kentaro Yamashita; Steering Committee: Toyoaki Murohara (chair), Takahisa Kondo, Satoshi Shintani, Kengo Maeda, Kunihiro Matsushita, Takashi Muramatsu, Kentaro Yamashita, Makoto Akahoshi, Haruo Hirayama, Satoshi Ichimiya, Masato Iida, Yoshio Iwama, Shinji Kaneko, Taizo Kondo, Nobuyuki Marui, Toshihiro Obayashi, Miyoshi Ohno, Osamu Ohno, Toshiyuki Osaka, Takahito Sone, Yasunobu Takada, Chiei Takanaka, and Masato Watarai; Endpoints Evaluation Committee: Tatsuaki Matsubara (chair), Kimihiro Komori, and Manabu Doyu; Data and Safety Monitoring Board: Hideaki Toyoshima (chair), Yutaka Oiso, and Makoto Hirai; Statistical Analysis Board: Nobuo Shirahashi (白橋伸雄); Writing and Subanalysis Study Committee: Toyoaki Murohara (chair), Takahisa Kondo, Satoshi Shintani, Kengo Maeda, Kunihiro Matsushita, Takashi Muramatsu, and Kentaro Yamashita; Clinical Research Coordinator and Data Management Group: Kumi Sasaki, Emiko Watanabe, and Yoko Inoue; and Investigators Participating in the NAGOYA HEART Study: Masayoshi Ajioka, Tetsuya Amano, Toru Aoyama, Yutaka Aoyama, Hiroshi Asano, Yoshizumi Asano, Tokiko Fuchino, Takaharu Fujimura, Ryoji Fukui, Yoshihiro Futamura, Yukihisa Hamaguchi, Yoshihiro Hanaki, Ken Harada, Mitsunori Harada, Shuji Harata, Hiroaki Harayama, Kazuyuki Haruta, Kazuki Hattori, Kazunori Hayashi, Yuzo Hayashi, Michitaka Hibino, Akihiro Hirashiki, Yoshio Ichihara, Shigeo Iino, Hajime Imai, Haruo Inagaki, Yasuya Inden, Natsuo Inoue, Atsushi Iseki, Hideki Ishii, Kyosuke Ishikawa, Shinichi Ishikawa, Shinji Ishikawa, Ryoji Ishiki, Satoshi Isobe, Atsushi Ito, Hirokazu Iwata, Hideo Izawa, Kenji Kada, Masahiro Kajiguchi, Haruo Kamiya, Hiroki Kamiya, Masaaki Kanashiro, Hitoshi Kanayama, Yoshiyuki Kataoka, Masataka Kato, Kimihiko Kato, Rinya Kato, Katsuhiro Kawaguchi, Hideki Kawai, Kei Kawakami, Toshiki Kawamiya, Shohei Kikuchi, Akira Kimura, Keita Kondo, Teruo Kondo, Masayoshi Koyasu, Nobutake Kurebayashi, Yasuko Kureishi-Bando, Yasunori Kushiyama, Seifuku Kyo, Mitsutaka Makino, Haruo Matsui, Yoshichika Matsui, Tatsuyuki Matsunami, Kazuhiro Matsuo, Satoshi Matsuyama, Sachio Mitani, Hirotsugu Mitsuhashi, Hiroshi Miyake, Shinji Mokuno, Shuji Morikawa, Ryuta Morimoto, Yasutsugu Morimoto, Yasuhiro Morita, Hisashi Murakami, Yoshihiro Murata, Masahiro Muto, Kazuyoshi Nagao, Kozo Nagata, Harumichi Nakagawa, Eishin Nakamura, Yoshihito Nakashima, Mamoru Nanasato, Yasuhiro Nishimoto, Hideya Nishimura, Yasuto Nishinaka, Takuya Nishiura, Takao Nishizawa, Manabu Niwa, Shoji Noda, Yasushi Numaguchi, Yasuhiro Ogawa, Shozo Ogawa, Yasuhiro Ogura, Mitsutoshi Oguri, Taiki Ohashi, Jun Ohno, Takashi Okashiro, Kenji Okumura, Kei Oshima, Naohiro Osugi, Masahiro Oya, Yoshihiro Saburi, Makoto Saito, Kazuyoshi Sakai, Shinichi Sakai, Hiroaki Sano, Bummei Sato, Ken Sawada, Kohei Sawasaki, Tetsuo Shibata, Yukio Shiga, Toshimasa Shigeta, Masayuki Shimano, Atsuya Shimizu, Kiyokazu Shimizu, Masanori Shinoda, Toshikazu Sobue, Mikio Sugino, Shigeo Sugino, Hiroki Sugiura, Hirohiko Suzuki, Noriyuki Suzuki, Tomoyuki Suzuki, Toru Tajika, Katsumasa Takagi, Kensuke Takagi, Ryotaro Takahashi, Hiroki Takanari, Kenji Takemoto, Yoshio Takemoto, Kyosuke Takeshita, Susumu Takeuchi, Toyonari Takeuchi, Atsushi Tanaka, Toshikazu Tanaka, Toshiro Tanaka, Yasushi Tatematsu, Akihiro Terasawa, Mamoru Tokuda, Masayuki Torigoe, Toshio Torii, Takanobu Toriyama, Hideyuki Tsuboi, Naoya Tsuboi, Hideto Tsukamoto, Issei Uchida, Tomohiro Uchikawa, Yusuke Uemura, Tadayuki Uetani, Hisashi Umeda, Hiroki Watanabe, Michiharu Yamada, Minoru Yamada, Takashi Yamada, Takashi Yamamoto, Masaki Yamauchi, Kenichiro Yokoi, Kiminobu Yokoi, Kiyoshi Yokoi, Eriko Yokoyama, Tomohiro Yoshida, Yukihiko Yoshida, and Mari Yoshikane.

Footnotes

  • This trial has been registered at www.clinicaltrials.gov (identifierNCT00129233).





    J Cardiol. 2010 Jul;56(1):111-7. doi: 10.1016/j.jjcc.2010.03.004. Epub 2010 Apr 20.

    Rationale and design of the NAGOYA HEART Studycomparison between valsartan and amlodipine regardingmorbidity and mortality in patients with hypertension and glucose intolerance.

    Matsushita K, Muramatsu T, Kondo T, Maeda K, Shintani S, Murohara T; NAGOYA HEART Study Group.

    Collaborators (37)

    Source

    Department of Cardiology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya 466-8550, Japan.

    Funding and conflict of interest

    The study is funded by Nagoya University Graduate School of Medicine. The Department of Cardiology, Nagoya University Graduate School of Medicine has received donation grants from various pharmaceutical companies. However, the research topics of these donation grants are not restricted. The Executive Committee has full access to all the data at the end of the study, and has final responsibility for the decision to submit for publication.

    The Statistical Analysis Board 
    Nobuo Shirahashi 白橋伸雄, Department of Preventive Medicine and Environmental Health, Osaka City University Medical School, Osaka, Japan.






0 件のコメント:

コメントを投稿